- You do not have any products in your shopping cart yet.
LONGSEE Corona test, 25 pcs. swab prefilled
.png "Guangdong Longsee Biomedical Co., Ltd.")
- Description
- Product presentation
- Instruction Manual
- CE Certificate
- Statement- Variants
- Manufacturer
- Customer reviews
You need larger quantities, for less condition?
Visit bagobag.com
Sold out? Order directly on bagobag.com
Quality Tested
Description: Longsee Antigen Rapid Test is an immunochromatographic test for the rapid, qualitative detection of antigens of novel coronaviruses (2019-nCoV) collected from nasopharyngeal or oropharyngeal swabs.
BfArM registration number: AT731/21
Specificity: 99,72%
Sensitivity: 95,51%
Dimensions: 21x14x7,2cm
Weight: 0,25kg
BfArM registration number: AT731/21
Specificity: 99,72%
Sensitivity: 95,51%
Dimensions: 21x14x7,2cm
Weight: 0,25kg
Quick shipping
Information: The Federal Institute for Pharmaceuticals and Medical Devices (BfArM) has approved this antigen test for self-use by laypersons.Evaluated by the Paul Ehrlich Institute.
This means that you can test yourself for SARS-CoV-2 infection quickly and easily at any time.
Whether visiting family or in restaurants and other public as well as cultural institutions. Self-testing is becoming an important part of pandemic containment efforts.
Comfortable nasal swab method.
Delivery:
- Germany: 2-3 days after order.
- Austria & Switzerland: within 3-4 days after order.
Shipping:
- Austria: Express 25 € per carton.
- Switzerland: Express 30 € per carton.
Keywords: 25 test kits per packaging unit (PU). Each test kit is again individually, conveniently and securely packaged.
Short keywords: Antigen test Longsee - Antigen test buy - Antigen test negative - Antigen test at home Corona - Antigen test make - Antigen test rapid test - Antigen test company buy - Antigen test mandatory - Antigen test front nasal area - Antigen test where buy - Antigen test how far into the nose - Antigen test from employer
Produktvorstellung
European conformity
CE mark
The CE mark indicates that the product may be traded freely in any part of the European Economic Area, regardless of its country of origin. It consists of the CE logo and, if applicable, the four digit identification number of the notified body involved in the conformity assessment procedure
Omicron
Statement
To whom it may concern,
In response to the recent updated multiple variants of the novel coronavirus, we, Guangdong Longsee Biomedical Co.,Ltd., as a manufacturer of 2019-nCo V Ag Rapid Detection Kit (Immuno-Chromatography) (LS-C-T-008/009), hereby declare that these products remain effective for the detection of SARS-Co V-2 antigen in discovered variants.
The variants include but not limited to the novel coronavirus variants such as
In response to the recent updated multiple variants of the novel coronavirus, we, Guangdong Longsee Biomedical Co.,Ltd., as a manufacturer of 2019-nCo V Ag Rapid Detection Kit (Immuno-Chromatography) (LS-C-T-008/009), hereby declare that these products remain effective for the detection of SARS-Co V-2 antigen in discovered variants.
The variants include but not limited to the novel coronavirus variants such as
- Alpha (B.1.1.7),
- Beta (B. l.351/B.1.351.2/B. l.351.3),
- Gamma (P. l/P. l. l/P.1.2),
- Delta (B.1.617.2/ A Y.1/A Y.2),
- Eta(B.1.525),
- lota(B.1.526),
- Kappa(B.1.617.1),
- Lambda(C.37),
- Zeta(P.2),
- Theta(P.3),
- Epsilon (B.1.427/B.1.429),
- and Omicron(B. 1.1.529/BA.2.12.1/BA.4/BA.5)
- etc.
The detection target of our antigen test kits is the nucleocapsid protein (nucleoprotein or protein N) antigens, but these mutations of variants occurred in the spike protein and hardly affect nucleocapsid protein. Therefore, we confirm our products can detect these variants.
Thank you for choosing LONGSEE products, we will continue to track and update the latest viral information including mutations and substitutions for SARS-Co V-2 to upgrade the specificity and sensitivity of our products and strengthen our research and development to provide you with high quality products and services.
Longsee Biomedical
Longsee Biomedical is a national-level high-tech enterprise dedicated to the development and production of core technologies, data and products of "intestinal microecological clinical medicine and health management". Its industries include five major areas: IVD (reagents + equipment), functional food, Holistic intestinal flora transplantation (FMT), living biological medicine and medical care services (clinical scientific research, medical testing, AI+ Internet medical treatment, high-end health care clinic). Longsee Biomedical has R&D, data, technical service, and business bases in Guangzhou, Beijing, Nanjing, Chongqing, Wuhan, Singapore and so on.
Adresse：5/F Building A, No.83,Ruihe Road, Huangpu District, PC 510000, Guangzhou, China
Unfortunately there are no review yet. Be the first who rate this product.